Viewing Study NCT07349394


Ignite Creation Date: 2026-03-26 @ 3:19 PM
Ignite Modification Date: 2026-03-31 @ 7:23 AM
Study NCT ID: NCT07349394
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2026-03-10
First Post: 2026-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Vanzacaftor/Tezacaftor/Deutivacaftor (VNZ/TEZ/D-IVA) on the PK of Rosuvastatin in Healthy Participants
Sponsor: Vertex Pharmaceuticals Incorporated
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module